Similarly, high CDCA3 expression is strongly associated with diminished overall survival (OS) in glioma patients, as evidenced by the CGGA and Rembrandt databases (both yielding P < .0001, as depicted in Figure 2B and C, respectively). The gene discussed is CDCA3; the disease is central nervous system cancer.